Antithrombotic strategy in the three first months following bioprosthetic heart valve implantation. - Wikidata - awgldk - TriplyDB

Antithrombotic strategy in the three first months following bioprosthetic heart valve implantation.

Antithrombotic strategy in the three first months following bioprosthetic heart valve implantation.

http://www.wikidata.org/entity/Q33843461

about

Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study.Public health policy based on "made-in-Brazil" Science: a challenge for the Arquivos Brasileiros de Cardiologia.

P2860

Q36923986-F71B3A7A-1627-4281-A5D9-604FA2F2CD1B Q43233971-9CE262EB-F5A7-4B64-B3CD-5EC5BDD185E8

P2860

Antithrombotic strategy in the three first months following bioprosthetic heart valve implantation.

http://www.wikidata.org/entity/Q33843461

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Antithrombotic strategy in the ...... etic heart valve implantation.

@ast

Antithrombotic strategy in the ...... etic heart valve implantation.

@en

type

label

Antithrombotic strategy in the ...... etic heart valve implantation.

@ast

Antithrombotic strategy in the ...... etic heart valve implantation.

@en

prefLabel

Antithrombotic strategy in the ...... etic heart valve implantation.

@ast

Antithrombotic strategy in the ...... etic heart valve implantation.

@en

P1433

Q33843461-C4D4FBC9-5F6E-4479-BCE1-67D2382CEB14

P1476

Q33843461-17199DD5-32CE-4D06-9900-4CCD9F92F846

P2093

Q33843461-01216700-288C-46DD-947F-55DD88BB4C70

Q33843461-302A2BF8-ABE9-4384-8483-B0B1E941C8B4

Q33843461-B6B7849C-02E4-41AE-B52D-469CE5B9CEA8

Q33843461-F7773B21-6918-4B2A-9D68-089D0569CC58

P275

Q33843461-F930EF0D-E372-4F5E-995E-499D6F87E17E

P2860

Q33843461-0ED962E0-7D5D-458B-8155-3E7E85BD508F

Q33843461-22B3DAE6-DD64-4355-8CF6-A205FB196A49

Q33843461-308F7A93-1943-45B9-B257-C4EBF68BB641

Q33843461-565FAF5B-1F53-4733-A7AD-6E4EE3D1266F

Q33843461-5A458230-B0A5-4D06-92AF-28747B1C9116

Q33843461-5D230D1F-E899-43D1-9DCE-4CDA0582DFE1

Q33843461-61AC9596-9AEF-4921-9E3D-4D21F6D4E40D

Q33843461-6E1EB6A3-1FC5-411F-A695-AF253921F0D3

Q33843461-758F6485-FB20-4AF7-9B4F-E06595730823

Q33843461-7EEA0E43-B8C5-4F21-8588-AC2A2E09F1C7

P304

Q33843461-9B2827F0-EB0F-4B3B-A64A-F79F65ED9B99

P31

Q33843461-D141619F-D6D6-4832-AEAC-BDE7BFBB91B2

Q33843461-EF977906-5EB5-458C-9D83-3F3B8A6F4B51

P356

Q33843461-CB5CF1A4-4679-4DB3-A28E-29F37CC059D6

P433

Q33843461-EC1D3622-C339-4F50-B2A9-05120783F737

P478

Q33843461-6D48A232-7DC5-44A3-A164-9AA91110E991

P577

Q33843461-802ACAFC-CD5B-44D1-85C0-FB06C239BACA

Q33843461-E7185C3B-51E2-492E-B494-F9FEB2EFED2C

P5875

Q33843461-1DF71494-0CEC-4164-B556-4EC3F9194427

P698

Q33843461-03E2B7D7-19F3-49F1-81FF-5195B3B58C17

P921

Q33843461-5E0CDD39-CE9F-43D3-BC48-A05B9A8A6EFD

Q33843461-84D6C118-44DD-4CEF-B03C-E86EE1314324

Q33843461-8BFF9B66-241C-450E-A776-AD89A8907D34

P932

Q33843461-84FF2879-D2F8-48A0-8F99-359D1FDA7F5B

P356

P1433

Arquivos Brasileiros De Cardiologia

P1476

Antithrombotic strategy in the ...... etic heart valve implantation.

@en

P2093

André R Durães

http://www.w3.org/2001/XMLSchema#string

Luis C L Correia

http://www.w3.org/2001/XMLSchema#string

Milena A O Durães

http://www.w3.org/2001/XMLSchema#string

Roque Aras

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 3.0 Unported

P2860

Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study

Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors

Rheumatic heart disease.

2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Commit

Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Antithrombotic therapy following bioprosthetic aortic valve replacement.

Long-term follow-up of the Hancock bioprosthetic heart valve: a 6-year review.

The long-term results of aortic valve replacement.

[Brazilian guidelines for the diagnosis, treatment and prevention of rheumatic fever].

Instantaneous risk of events following aortic valve replacement with pericardial valves: a ten-year experience.

P304

466-472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5935/ABC.20130202

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257530272

http://www.w3.org/2001/XMLSchema#string

P698

24100694

http://www.w3.org/2001/XMLSchema#string

P921

mechanism of action

P932

4081171

http://www.w3.org/2001/XMLSchema#string